Nanosonics Future Growth

Future criteria checks 4/6

Nanosonics is forecast to grow earnings and revenue by 24% and 8.7% per annum respectively. EPS is expected to grow by 23.8% per annum. Return on equity is forecast to be 11.2% in 3 years.

Key information

24.0%

Earnings growth rate

23.8%

EPS growth rate

Medical Equipment earnings growth	16.1%
Revenue growth rate	8.7%
Future return on equity	11.2%
Analyst coverage	Good
Last updated	12 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

CHIA:NAN - Analysts future estimates and past financials data (AUD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2027	227	28	28	36	9
6/30/2026	208	18	19	24	10
6/30/2025	188	13	14	18	10
6/30/2024	170	13	20	23	N/A
3/31/2024	167	14	21	23	N/A
12/31/2023	164	16	22	24	N/A
9/30/2023	165	18	21	24	N/A
6/30/2023	166	20	20	23	N/A
3/31/2023	154	15	15	20	N/A
12/31/2022	141	10	10	16	N/A
9/30/2022	131	7	5	11	N/A
6/30/2022	120	4	0	7	N/A
3/31/2022	120	7	2	7	N/A
12/31/2021	121	11	4	8	N/A
9/30/2021	112	10	5	8	N/A
6/30/2021	103	9	6	7	N/A
3/31/2021	99	7	7	9	N/A
12/31/2020	95	6	8	10	N/A
9/30/2020	97	8	15	16	N/A
6/30/2020	100	10	21	23	N/A
3/31/2020	96	11	16	18	N/A
12/31/2019	92	12	11	13	N/A
9/30/2019	88	13	7	9	N/A
6/30/2019	84	14	3	5	N/A
3/31/2019	78	12	3	6	N/A
12/31/2018	71	11	4	6	N/A
9/30/2018	66	8	5	8	N/A
6/30/2018	61	6	6	9	N/A
3/31/2018	61	6	N/A	11	N/A
12/31/2017	61	6	N/A	13	N/A
9/30/2017	64	16	N/A	15	N/A
6/30/2017	68	26	N/A	16	N/A
3/31/2017	65	26	N/A	16	N/A
12/31/2016	63	25	N/A	16	N/A
9/30/2016	53	13	N/A	10	N/A
6/30/2016	43	0	N/A	3	N/A
3/31/2016	33	-5	N/A	-3	N/A
12/31/2015	23	-10	N/A	-8	N/A
9/30/2015	23	-8	N/A	-5	N/A
6/30/2015	22	-5	N/A	-2	N/A
3/31/2015	24	-2	N/A	0	N/A
12/31/2014	26	2	N/A	2	N/A
9/30/2014	24	0	N/A	0	N/A
6/30/2014	21	-3	N/A	-3	N/A
3/31/2014	21	-3	N/A	-3	N/A
12/31/2013	20	-3	N/A	-3	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NAN's forecast earnings growth (24% per year) is above the savings rate (2.6%).

Earnings vs Market: NAN's earnings (24% per year) are forecast to grow faster than the Australian market (12.4% per year).

High Growth Earnings: NAN's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: NAN's revenue (8.7% per year) is forecast to grow faster than the Australian market (5.7% per year).

High Growth Revenue: NAN's revenue (8.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: NAN's Return on Equity is forecast to be low in 3 years time (11.2%).

Nanosonics Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Nanosonics Limited Provides Revenue Guidance for the Fiscal Year 2022

Nanosonics Limited Provides Earnings Guidance for the Fiscal Year 2022

Nanosonics Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021

Recent updates

Nanosonics Limited Announces Board Retirements

Nanosonics Limited, Annual General Meeting, Nov 12, 2024

Investor sentiment improves as stock rises 19%

New minor risk - Profit margin trend

Full year 2024 earnings released: EPS: AU$0.043 (vs AU$0.066 in FY 2023)

Nanosonics Limited to Report Fiscal Year 2024 Results on Aug 27, 2024

Independent Non-Executive Director recently sold AU$304k worth of stock

New minor risk - Insider selling

Key Executive recently bought AU$100k worth of stock

First half 2024 earnings released: EPS: AU$0.02 (vs AU$0.034 in 1H 2023)

Investor sentiment deteriorates as stock falls 30%

Now 37% undervalued after recent price drop

Nanosonics Limited to Report First Half, 2024 Results on Feb 26, 2024

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Nanosonics Limited Announces Appointment of Jason Burriss as Chief Financial Officer, Effective 3 October 2023

Nanosonics Limited Appoints Larry Marshall as Non- Executive Director, Effective from 3 October 2023

Nanosonics Limited, Annual General Meeting, Nov 03, 2023

Full year 2023 earnings released: EPS: AU$0.066 (vs AU$0.012 in FY 2022)

Nanosonics Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Nanosonics Limited Announces the Appointment of Tracey Batten as Non-Executive Director, Effective 26 September 2023

CEO, President recently sold AU$121k worth of stock

Nanosonics Announces Company Secretary Changes

Independent Non-Executive Director recently sold AU$504k worth of stock

First half 2023 earnings released

Nanosonics Limited to Report First Half, 2023 Results on Feb 23, 2023

Insufficient new directors

Insufficient new directors

Now 20% undervalued

CEO, President recently sold AU$960k worth of stock

Full year 2022 earnings released: EPS: AU$0.012 (vs AU$0.029 in FY 2021)

Nanosonics Limited, Annual General Meeting, Nov 18, 2022

Nanosonics Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Insufficient new directors

Nanosonics Limited Provides Revenue Guidance for the Fiscal Year 2022

Now 21% undervalued after recent price drop

Nanosonics Limited Announces Management Changes

First half 2022 earnings: Revenues and EPS in line with analyst expectations

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Nanosonics Limited to Report First Half, 2022 Results on Feb 22, 2022

Full year 2021 earnings released: EPS AU$0.029 (vs AU$0.034 in FY 2020)

Nanosonics Limited Provides Earnings Guidance for the Fiscal Year 2022

Nanosonics to Launch Digital Platform for Infection Control

First half 2021 earnings released: EPS AU$0.005 (vs AU$0.019 in 1H 2020)

Revenue misses expectations

New 90-day low: AU$6.41

Nanosonics Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$7.85

New 90-day high: AU$6.72

I-MED Signs Agreement with Nanosonics to Upgrade Their Trophon EPR Fleet to Trophon2

Nanosonics Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021

Earnings released

New 90-day low - AU$5.92

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies